# Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China

> **NCT04762472** · PHASE4 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 200 (estimated)

## Conditions studied

- Atherosclerosis, Coronary

## Interventions

- **DRUG:** Montelukast Oral Tablet
- **DRUG:** Montelukast Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT04762472
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04762472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04762472, "Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04762472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*